Form 4 for WST West Pharmaceutical Services
Accepted 2023-11-02 00:00:00 ET · period of report 2023-10-31 · accession 0001127602-23-026551 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-11-02 | 2023-10-31 | WST | Witherspoon Charles | VP, Treas | M - OptEx | $223.84 | +1,190 | 3,025 | +65% | +$266.4K |
| DM | 2023-11-02 | 2023-10-31 | WST | Witherspoon Charles | VP, Treas | S - Sale+OE | $322.37 | -1,190 | 1,835 | -39% | -$383.6K |
| DM | 2023-11-02 | 2023-10-31 | WST | Witherspoon Charles | VP, Treas | M - OptEx | $0.00 | -1,190 | 596 | -67% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-31 | M | A | 594 | $173.22 | 2,429.09 | D | — | — | |
| 2 | Common | Common Stock | 2023-10-31 | M | A | 596 | $274.29 | 3,025.09 | D | — | — | |
| 3 | Common | Common Stock | 2023-10-31 | S | D | 594 | $322.48 | 2,431.09 | D | — | — | |
| 4 | Common | Common Stock | 2023-10-31 | S | D | 596 | $322.27 | 1,835.09 | D | — | — | |
| 5 | Derivative | Stock Options (Right to Buy) | 2023-10-31 | M | D | 594 | $0.00 | 478 | D | $173.22 · 2021-02-18 to 2030-02-18 | 594 Stock Options (Right to Buy) | (F1) This award vests in four equal annual installments beginning on February 18, 2021. |
| 6 | Derivative | Stock Options (Right to Buy) | 2023-10-31 | M | D | 596 | $0.00 | 596 | D | $274.29 · 2022-02-23 to 2031-02-23 | 596 Stock Options (Right to Buy) | (F2) This award vests in four equal annual installments beginning on February 23, 2022. |